Evidence map›Paper›PMID 33835024›Full record

ArticleeLife2021

Simultaneous trimodal single-cell measurement of transcripts, epitopes, and chromatin accessibility using TEA-seq.

Elliott Swanson, Cara Lord, Julian Reading, Alexander T Heubeck, Palak C Genge, Zachary Thomson, Morgan DA Weiss, Xiao-Jun Li, Adam K Savage, Richard R Green and 4 more

Abstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 174 papers.

0numbers the graph read from it
0cells of the map it votes in
174citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

174 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Unifying multimodal single-cell data with a mixture-of-expertsbioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

114 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Elliott SwansonAllen Institute for Immunology, Seattle, United States.ORCID http://orcid.org/0000-0002-0351-6446
Cara LordAllen Institute for Immunology, Seattle, United States.ORCID http://orcid.org/0000-0002-7827-2159
Julian ReadingAllen Institute for Immunology, Seattle, United States.ORCID http://orcid.org/0000-0002-8533-3992
Alexander T HeubeckAllen Institute for Immunology, Seattle, United States.ORCID http://orcid.org/0000-0002-9312-4090
Palak C GengeAllen Institute for Immunology, Seattle, United States.ORCID https://orcid.org/0000-0002-0851-6445
Zachary ThomsonAllen Institute for Immunology, Seattle, United States.ORCID https://orcid.org/0000-0002-3861-9998
Morgan DA WeissAllen Institute for Immunology, Seattle, United States.ORCID https://orcid.org/0000-0002-4189-1992
Xiao-Jun LiAllen Institute for Immunology, Seattle, United States.ORCID http://orcid.org/0000-0003-0832-9479
Adam K SavageAllen Institute for Immunology, Seattle, United States.ORCID http://orcid.org/0000-0003-1913-5485
Richard R GreenAllen Institute for Immunology, Seattle, United States.ORCID https://orcid.org/0000-0001-8851-7204
Troy R TorgersonAllen Institute for Immunology, Seattle, United States.ORCID https://orcid.org/0000-0003-3489-5036
Thomas F BumolAllen Institute for Immunology, Seattle, United States.ORCID https://orcid.org/0000-0003-4319-1006
Lucas T GraybuckAllen Institute for Immunology, Seattle, United States.ORCID https://orcid.org/0000-0002-8814-6818
Peter J SkeneAllen Institute for Immunology, Seattle, United States.ORCID https://orcid.org/0000-0001-8965-5326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-cell measurements of cellular characteristics have been instrumental in understanding the heterogeneous pathways that drive differentiation, cellular responses to signals, and human disease. Recent advances have allowed paired capture of protein abundance and transcriptomic state, but a lack of epigenetic information in these assays has left a missing link to gene regulation. Using the heterogeneous mixture of cells in human peripheral blood as a test case, we developed a novel scATAC-seq workflow that increases signal-to-noise and allows paired measurement of cell surface markers and chromatin accessibility: integrated cellular indexing of chromatin landscape and epitopes, called ICICLE-seq. We extended this approach using a droplet-based multiomics platform to develop a trimodal assay that simultaneously measures transcriptomics (scRNA-seq), epitopes, and chromatin accessibility (scATAC-seq) from thousands of single cells, which we term TEA-seq. Together, these multimodal single-cell assays provide a novel toolkit to identify type-specific gene regulation and expression grounded in phenotypically defined cell types.

Indexed as

Gene Expression RegulationTranscriptomeChromatinEpigenomicsEpitopesHumansSingle-Cell AnalysisChromatinEpitopeschromatinepitopesgeneticsgenomicshumanimmunologyinflammationmultiomicssequencingtranscription

Identifiers

PMID33835024
PMCPMC8034981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.